Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 10.47B | $ 11.25B | $ 10.02B | $ 9.48B | $ 8.25B |
Total Assets | $ 10.99B | $ 11.68B | $ 10.48B | $ 9.90B | $ 8.74B |
Total Debt | $ 109.20M | $ 109.40M | $ 111.00M | $ 110.40M | $ 109.70M |
Net Debt | $ -10.36B | $ -11.14B | $ -9.91B | $ -9.37B | $ -8.14B |
Total Liabilities | $ 10.66B | $ 11.34B | $ 10.19B | $ 9.65B | $ 8.52B |
Stockholders Equity | $ 338.50M | $ 341.50M | $ 286.70M | $ 253.20M | $ 217.10M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |